Michael A. Proschan

National Institute of Allergy and Infectious Diseases

MathematicsEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19”.

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine(2020)10.1056/nejmoa2031994

N/A

6.8DataRank · unranked

1924 citations

Thomas F. Patterson, Aneesh K. Mehta, Kay M Tomashek, Cameron R. Wolfe, Varduhi Ghazaryan +55 more

Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa270

N/A

1.6DataRank · unranked

37 citations

Erin Huiting, Katherine E. Clarridge, Catherine Seamon, Jana Blažková, J. Shawn Justement +8 more

Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19

medRxiv(2022)10.1101/2022.09.22.22280245

N/A

0.464DataRank · unranked

9 citations

Eyal Kedar, Kevin J. Anstrom, Matthew W. McCarthy, Emily R. Ko, Patricia Segura Nunez +38 more

Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption

Frontiers in Medicine(2022)10.3389/fmed.2022.979756

N/A

0.208DataRank · unranked

3 citations

Matthew A. Adan, Jessica Earhart, Cassie Seamon, Thuy Nguyen, Ariana Savramis +16 more

Endpoints for randomized controlled clinical trials for COVID-19 treatments

Clinical Trials(2020)10.1177/1740774520939938

N/A

0DataRank · unranked

4 citations

Dean Follmann, Jing Wang, Franz Koenig, Lisa L. Korn, Christian Schoergenhofer +10 more

Reply to Villar et al

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1029

N/A

0DataRank · unranked

3 citations

Scott Evans, Michael A. Proschan

Reply to Chandereng and Chappell

Clinical Infectious Diseases(2021)10.1093/cid/ciaa1377

N/A

0DataRank · unranked

0 citations

Scott Evans, Michael A. Proschan

Combination anti-HIV antibodies provide sustained virological suppression

Nature(2022)10.1038/s41586-022-04797-9

N/A

0DataRank · unranked

178 citations

Jana Blažková, J. Shawn Justement, Victoria Shi, Brooke D. Kennedy, Kathleen Gittens +15 more

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

Cell(2022)10.1016/j.cell.2022.09.032

N/A

0DataRank · unranked

68 citations

Lela Kardava, Omar El Merhebi, Sandeep Narpala, Leonid Serebryannyy, Bob C. Lin +17 more

The Effect of GS‐548351 on the Pharmacokinetics of Midazolam Following Multiple Doses of ANS‐6637 in Healthy Adults

The Journal of Clinical Pharmacology(2020)10.1002/jcph.1672

N/A

0DataRank · unranked

1 citations

Elana Rosenthal, Poonam Mathur, Mary McLaughlin, Michael A. Proschan, Arjun Vijan +6 more

Resist the Temptation of Response-Adaptive Randomization

Clinical Infectious Diseases(2020)10.1093/cid/ciaa334

N/A

0DataRank · unranked

61 citations

Scott Evans, Michael A. Proschan

Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination

medRxiv(2022)10.1101/2022.08.30.22279344

N/A

0DataRank · unranked

1 citations

Lela Kardava, Omar El Merhebi, Sandeep Narpala, Leonid Serebryannyy, Bob C. Lin +17 more

Persistence of Human Immunodeficiency Virus–Associated Cerebral Toxoplasmosis Lesions in Successfully Treated Patients Receiving Combination Antiretroviral Therapy

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad208

N/A

0DataRank · unranked

4 citations

Bryan Smith, Rama Kapoor, Michael A. Proschan, Irini Sereti, Dima A. Hammoud +2 more

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.1

N/A

0DataRank · unranked

1 citations

Kevin J. Anstrom, Christina E. Barkauskas, Samuel M. Brown, Eric S. Daar, William A. Fischer +16 more

Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical Trial

Clinical Trials(2024)10.1177/17407745241244801

N/A

0DataRank · unranked

0 citations

Eric Leifer, Michael A. Proschan, James Troendle, Harmony R. Reynolds, Erinn A Hade +4 more

Does Remdesivir Lower COVID‐19 Mortality? A Subgroup Analysis of Hospitalized Adults Receiving Supplemental Oxygen

Statistics in Medicine(2024)10.1002/sim.10241

N/A

0DataRank · unranked

0 citations

Michael A. Proschan, Gail E. Potter

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

UNC Libraries(2024)10.17615/wtgx-4h88

N/A

0DataRank · unranked

0 citations

Mahesh Parmar, Roger Paredes, Kevin J. Anstrom, Stacey J. Adam, Seema Nayak +16 more

Futility Monitoring in Clinical Trials

Statistics in Medicine(2025)10.1002/sim.70157

N/A

0DataRank · unranked

1 citations

Megan C. Grieco, Kevin Rubenstein, Jing Wang, Michael A. Proschan, Ana M. Ortega‐Villa